EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

In Silico Study of Dysotriflorin Compounds from Majegau Stem Bark (Dysoxylum densiflorum) as a Potential Antihypertensive Agent

Putu Esya Elistya, Ni Wayan Rika Kumara Dewi, Ni Luh Gde Mona Monika

JURNAL FARMASIMED (JFM) · 30.10.2026 · 9 (1) · 188-199

DOI: 10.35451/jfm.v9i1.3837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JURNAL FARMASIMED (JFM), online erschienen am 30.10.2026. Verfasst von Putu Esya Elistya und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is a non-communicable disease with high prevalence in Indonesia and a major risk factor for cardiovascular disorders. The Renin-Angiotensin-Aldosterone System (RAAS) plays a crucial role in its pathophysiology through activation of Angiotensin-Converting Enzyme (ACE) and Angiotensin II type 1 receptor (AT1R). This study investigates the potential of dysotriflorin A–M, triterpenoid metabolites from the bark of majegau (Dysoxylum densiflorum), as antihypertensive candidates using an in-silico approach. The methods included preparation of ACE and AT1R proteins, optimization of the compound’s 3D structures, and molecular docking simulations with AutoDock Vina. Interaction analysis assessed binding affinity, bond types, and amino acid residues, complemented by toxicity prediction (ProTox) and bioavailability evaluation (Lipinski’s rule). Results showed dysotriflorin A–M had binding affinities ranging from –8.5 to –9.4 kcal/mol for ACE and –8.1 to –9.0 kcal/mol for AT1R, outperforming captopril (–7.4 kcal/mol) and losartan (–8.1 kcal/mol). Hydrogen and hydrophobic interactions supported complex stability. Toxicity prediction indicated LD50 of 2000 mg/kg (class IV, relatively safe), while bioavailability met 4 of 5 Lipinski parameters. In conclusion, dysotriflorin A–M demonstrates promising potential as a natural antihypertensive candidate with favorable safety and bioavailability, warranting further in-vitro and in-vivo validation.

Zitieren

APA

Elistya, P. E., Dewi, N. W. R. K., & Monika, N. L. G. M. (2026). In Silico Study of Dysotriflorin Compounds from Majegau Stem Bark (Dysoxylum densiflorum) as a Potential Antihypertensive Agent. JURNAL FARMASIMED (JFM), 9(1), 188-199. https://doi.org/10.35451/jfm.v9i1.3837

Vancouver

Elistya PE, Dewi NWRK, Monika NLGM. In Silico Study of Dysotriflorin Compounds from Majegau Stem Bark (Dysoxylum densiflorum) as a Potential Antihypertensive Agent. JURNAL FARMASIMED (JFM). 2026;9(1):188-199. doi:10.35451/jfm.v9i1.3837

BibTeX
@article{Elistya2026,
  author = {Elistya, Putu Esya and Dewi, Ni Wayan Rika Kumara and Monika, Ni Luh Gde Mona},
  title = {In Silico Study of Dysotriflorin Compounds from Majegau Stem Bark (Dysoxylum densiflorum) as a Potential Antihypertensive Agent},
  journal = {JURNAL FARMASIMED (JFM)},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {188--199},
  doi = {10.35451/jfm.v9i1.3837}
}
Kostenlos starten →